Cyclosporin A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis

Biochem J. 1991 Apr 15;275 ( Pt 2)(Pt 2):501-5. doi: 10.1042/bj2750501.

Abstract

Bile acid synthesis, determined by conversion of [4-14C]cholesterol into bile acids in rat and human hepatocytes and by measurement of mass production of bile acids in rat hepatocytes, was dose-dependently decreased by cyclosporin A, with 52% (rat) and 45% (human) inhibition of 10 microM. The decreased bile acid production in rat hepatocytes was due only to a fall in the synthesis of beta-muricholic and chenodeoxycholic acids (-64% at 10 microM-cyclosporin A), with no change in the formation of cholic acid. In isolated rat liver mitochondria, 26-hydroxylation of cholesterol was potently inhibited by the drug (concn. giving half-maximal inhibition = 4 microM). These results suggest that cyclosporin A blocks the alternative pathway in bile acid synthesis, which leads preferentially to the formation of chenodeoxycholic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bile Acids and Salts / antagonists & inhibitors
  • Bile Acids and Salts / biosynthesis*
  • Bile Acids and Salts / isolation & purification
  • Cells, Cultured
  • Chenodeoxycholic Acid / antagonists & inhibitors
  • Chenodeoxycholic Acid / biosynthesis*
  • Cholesterol / metabolism*
  • Cyclosporins / pharmacology*
  • Humans
  • Kinetics
  • Liver / drug effects
  • Liver / metabolism*
  • Rats

Substances

  • Bile Acids and Salts
  • Cyclosporins
  • Chenodeoxycholic Acid
  • Cholesterol